These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3235677)

  • 1. Evaluation of a commercial latex test for Clostridium difficile for reactivity with C. difficile and cross-reactions with other bacteria.
    Miles BL; Siders JA; Allen SD
    J Clin Microbiol; 1988 Nov; 26(11):2452-5. PubMed ID: 3235677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
    Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
    J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of the CD D-1 latex test with Clostridium difficile and other bacteria.
    Wongwanich S; Kusum M; Phan-Urai R
    Southeast Asian J Trop Med Public Health; 1994 Jun; 25(2):321-3. PubMed ID: 7855649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cross-reactive proteins detected by Culturette Brand Rapid Latex Test for Clostridium difficile.
    Lyerly DM; Ball DW; Toth J; Wilkins TD
    J Clin Microbiol; 1988 Mar; 26(3):397-400. PubMed ID: 3128574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.
    Peterson LR; Holter JJ; Shanholtzer CJ; Garrett CR; Gerding DN
    Am J Clin Pathol; 1986 Aug; 86(2):208-11. PubMed ID: 3739972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercial latex test for Clostridium difficile toxin A does not detect toxin A.
    Lyerly DM; Wilkins TD
    J Clin Microbiol; 1986 Mar; 23(3):622-3. PubMed ID: 3082928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a rapid latex test for the detection of Clostridium difficile in fecal specimens.
    Ryan RW; Kwasnik I; Clout D; Tilton RC
    Ann Clin Lab Sci; 1987; 17(4):232-5. PubMed ID: 3619398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests.
    Shanholtzer CJ; Willard KE; Holter JJ; Olson MM; Gerding DN; Peterson LR
    J Clin Microbiol; 1992 Jul; 30(7):1837-40. PubMed ID: 1629341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monospecific antibodies for detection of Clostridium difficile enterotoxin.
    Rautenberg P; Stender F; Ullmann U
    Eur J Clin Microbiol; 1987 Feb; 6(1):62-4. PubMed ID: 3552665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
    Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
    Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin.
    Kamiya S; Nakamura S; Yamakawa K; Nishida S
    Microbiol Immunol; 1986; 30(2):177-81. PubMed ID: 3086678
    [No Abstract]   [Full Text] [Related]  

  • 12. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis.
    Ryan RW
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):79S-86S. PubMed ID: 3516548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of C. diff.-CUBE test for detection of Clostridium difficile-associated diarrhea.
    Kurzynski TA; Kimball JL; Schultz DA; Schell RF
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):493-8. PubMed ID: 1424501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxin and faecal lactoferrin assays in adult patients.
    Vaishnavi C; Bhasin D; Kochhar R; Singh K
    Microbes Infect; 2000 Dec; 2(15):1827-30. PubMed ID: 11165926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Clostridium difficile-associated intestinal disease.
    Rolfe RD
    Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characteristics of toxigenic Clostridia and toxin gene evolution.
    Popoff MR; Bouvet P
    Toxicon; 2013 Dec; 75():63-89. PubMed ID: 23707611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.